H2, Inc.

NT$28.25As of Sun 8 Nov 2026, 12:00 UTC

TPEx:7851—

Country Taiwan

PE (Fwd) •••

TSR 10Y CAGR —

Div yield —

ROE —

—

Beta (5Y) —

PE TTM —

TSR TTM —

Mkt cap —

ROIC —

SE Grade™

Value

Quality

Moat

Consensus

Reference

NT$35

22.66%

135.49%

Hold 2|10|5|9|2

TTM

FYE 31 Dec TWD

FY2016

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

15.53

RevenueNT$B

37.26

37.72

39.46

40.80

42.87

44.88

45.43

47.73

48.74

50.95

16.39

3.51%

3.60%

2.12

Revenue growth%

24.36

24.28

23.10

24.09

25.16

22.75

24.81

24.94

27.09

28.48

24.94

24.32

2.21

Gross margin%

27.81

25.21

26.39

27.47

28.46

25.46

23.68

21.90

22.24

22.52

27.40

22.52

25.34

2.13

Operating margin%

27.30

28.60

26.36

23.48

22.33

22.13

21.52

22.11

20.85

18.63

26.13

21.52

22.23

7.28

Net margin%

21.17

20.65

23.41

25.98

26.26

25.12

25.55

25.19

25.57

28.33

21.06

25.55

25.37

9.238

P/E ratio (avg)x

37.99

39.72

39.47

43.63

47.04

51.25

52.75

53.05

51.73

53.00

16.35

52.75

49.14

11.88

EV/EBITx

19.61

20.41

18.03

16.93

17.48

18.88

19.29

20.67

18.82

17.19

36.28

18.88

18.85

8.88

FCF yield (avg)%

11.85

12.88

11.17

8.44

6.80

4.39

4.38

1.47

0.40

2.09

18.91

2.09

5.60

10.01

FCF margin%

24.91

24.57

27.46

30.02

31.43

29.36

29.14

26.51

28.76

30.51

28.45

29.14

28.95

1.260

FCF / Net incomex

1.520

1.407

1.449

1.255

1.383

1.326

1.399

1.342

1.426

1.519

1.120

1.399

1.403

21.34

ROIC%

16.36

17.64

19.72

22.48

20.41

21.40

21.33

19.54

20.59

18.83

5.88

20.59

20.07

15.12

Return on equity%

23.45

26.02

26.94

24.26

27.23

28.44

29.24

27.26

29.68

30.39

21.95

29.24

27.24

2.75

Return on assets%

16.65

14.82

15.89

18.05

20.18

22.09

20.94

18.37

17.90

20.38

26.62

20.38

18.21

5.12

EPSNT$

5.74

6.18

6.29

6.79

6.54

6.25

6.60

6.08

6.56

6.17

5.33

(1.17%)

(0.06%)

—

19.22

EPS growth%

6.25

4.51

6.84

4.89

2.76

4.46

4.40

6.19

7.08

4.76

9.29

4.76

4.83

1.00

Bookvalue per shNT$

5.91

5.90

6.36

6.77

5.92

5.09

4.80

4.30

3.94

3.34

5.88

(10.82%)

(6.81%)

—

4.94

FCF per shareNT$

5.44

5.05

5.28

5.11

5.21

4.83

4.57

4.54

0.94

(2.34%)

(0.93%)

—

5.88

Dividend per shNT$

4.57

3.99

4.01

4.07

3.59

3.47

3.53

3.15

3.37

2.96

3.52

(3.77%)

(4.53%)

—

2.02

Div yield (avg)%

21.94

23.97

25.93

27.41

26.96

24.83

22.31

22.89

20.23

20.43

29.41

22.31

23.43

16.00

Payout ratio%

19.48

16.76

14.58

16.08

13.32

13.34

11.59

11.00

11.49

13.39

7.54

11.59

13.36

2.372

Shares (diluted)B

2.342

2.356

2.226

2.390

2.701

2.744

2.731

2.656

2.508

2.537

2.389

(1.25%)

1.01%

7.65

Buyback yield%

19.54

21.91

23.06

21.68

23.02

25.13

26.05

28.30

25.89

28.72

19.53

26.05

24.09

0.448

D/E ratiox

0.611

0.609

0.579

0.532

0.589

0.536

0.510

0.481

0.456

0.434

0.298

0.481

0.534

31.58

Enterprise valueNT$B

78.71

91.76

93.67

97.16

115.6

127.2

131.8

149.4

159.7

167.1

5.480

7.64%

9.43%

30.55

LT debtNT$B

39.17

44.30

53.35

55.88

67.08

69.21

78.79

90.90

88.55

97.80

14.23

7.83%

10.46%

Peers (US$47.94M)

Cap (US$)

QSAN Technology Inc

62.58M

—

Lionic Corporation

37.59M

—

aetherAI Co., Ltd.

36.36M

—

Neosapience, Inc.

47.28M

—

Capital

TTM

10Y

Leveragex

0.631

0.063

0.069

EBIT/Intx

1.854

0.606

0.587

Own earn%

(138.57)

(81.61)

(85.22)

Sh yield%

9.67

49.15

49.04

Owners

Insiders/Inst%

0.79

29.68

Short interest%

5.74

SBC / revenue%

3.74

Record

10Y

Profitable years

10/10

Revenue growth years

10/10

EPS growth years

10/10

Dividend streakyrs

Op margin range%

19–29

$1 testx

0.0

Incr. ROIC%

H2, Inc. designs and develops a cloud-based health management platform that tracks blood sugar readings and related activities. It offers a mobile application that allows patients to manage blood glucose. The company's platform also allows health professionals to view patient's latest blood glucose readings and related activities.

Growth vs revenue

Latest

Trend

10Y CAGR

Rel growth

Revenue

NT$50.95B

3.60%

1.00×

Cost of revenue

NT$31.41B

3.37%

0.98×

Operating expenses

NT$8.124B

4.16%

1.06×